FIELD: medicine. SUBSTANCE: method involves introducing tumor growth inductor like ascitic Ehrlich carcinoma in concentration of 6,5-7,5•10-3 tumor cells per 1 ml into uterus horn. EFFECT: excluded toxicosis phenomena; enhanced effectiveness of tumor localization and growth control. 9 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CREATING ORTHOTOPIC ENDOMETRIAL CANCER MODEL | 2024 |
|
RU2818464C1 |
METHOD FOR MODELING OVARIAN CANCER EXPERIMENTALLY IN RATS | 2020 |
|
RU2743219C1 |
METHOD FOR SIMULATING LIVER METASTASES EXPERIMENTALLY | 2013 |
|
RU2538243C1 |
MEANS FOR TREATMENT OF MALIGNANT ASCITIC TUMOURS | 2011 |
|
RU2464974C1 |
METHOD OF CREATING MODEL OF UTERINE SARCOMA | 2024 |
|
RU2820404C1 |
METHOD FOR DIAGNOSIS OF METASTASES TO LYMPH NODES OF SMALL PELVIS IN PATIENTS WITH RESECTABLE CERVICAL CANCER | 2020 |
|
RU2750769C2 |
METHOD OF DIAGNOSING CANCER AND POTENTIAL RESISTANCE OF MALIGNANT CELLS TO HYPOXIA | 2011 |
|
RU2463963C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF FIBROADENOMA AND MAMMA CANCER | 1994 |
|
RU2092843C1 |
RAPID METHOD FOR DETERMINING RISK OF CELL MALIGNANCY | 2012 |
|
RU2508542C1 |
METHOD FOR PREPARING UTERINE NECK CARCINOMA PATIENTS OF THE III STAGE FOR MAKING OPERATION | 1996 |
|
RU2149661C1 |
Authors
Dates
2003-12-27—Published
2002-06-24—Filed